Stock QGEN QIAGEN N.V.
Add to a list
To use this feature you must be a member
Log inSign up

News Qiagen N.V. Swiss Exchange

Equities

QGEN

NL0015001WM6

Market Closed - Swiss Exchange
Other stock markets
 16:35:20 28/06/2019 BST 		5-day change 1st Jan Change
39.45 CHF +0.84% Intraday chart for Qiagen N.V. -.--% -.--%
05-31 Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test MT
05-31 Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test
MT
Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test
MT
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
AQ
QIAGEN and Myriad Genetics Develop Distributable Homologous Recombination Deficiency Test for Global Research and Companion Diagnostics Applications
CI
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine
AQ
Qiagen N.V. Launches New Library Preparation Kit, Facilitating Multiomic Studies and Advancing Precision Medicine
CI
QIAGEN NV : Berenberg maintains a Buy rating
ZD
Qiagen's Updated Clinical Decision Support Platform Secures EU Certification
MT
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support
AQ
QIAGEN Receives European IVDR Certification for QIAGEN Clinical Insight Interpret
CI
Qiagen N : 2023 Annual Report 2023 Sustainability Statement
PU
Qiagen Receives FDA Clearance for Clinical Use of Respiratory Infection Test
MT
Qiagen Obtains US FDA Clearance for Respiratory Syndromic Testing Panel
MT
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results
AQ
Qiagen Receives FDA Clearance for Qiastat-Dx Respiratory Syndromic Testing Panel for Fast and Accurate Results
CI
Qiagen N : 2024 QIAGEN N.V. Annual General Meeting of Shareholders Presentation
PU
Qiagen N : 2023 Annual Report 2023 Annual Financial Report
PU
Qiagen, US FBI to Jointly Develop Digital PCR Assay for Forensics
MT
Qiagen N : Annual Report 2023, including the Reports of the Managing Board and the Supervisory Board of N.V.
PU
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. QGEN Stock
  4. QGEN Stock
  5. News Qiagen N.V.